| abstract |
The present disclosure relates to compounds of formula (I) that are useful as modulators of α7 nAChR, compositions comprising such compounds, and centers such as cognitive impairment in diseases, particularly Alzheimer's disease, Parkinson's disease and schizophrenia. It relates to the use of such compounds for the prevention, treatment or amelioration of nervous system disorders and L-DOPA-induced movement disorders and inflammation. [Chemical 1] |